Supplementary Table S1.docx (20.8 kB)
Supplementary Table S1: Atogepant and sumatriptan: no clinically relevant drug-drug interactions in a randomized, open-label, crossover trial
dataset
posted on 2021-12-13, 15:57 authored by Ramesh Boinpally, Abhijeet Jakate, Matthew Butler, Antonia Periclou|
Supplementary Table 1. Atogepant and Sumatriptan: No Clinically Relevant Drug-Drug Interactions in a Randomized, Open-label, Crossover Trial
|
